https://www.selleckchem.com/products/Nolvadex.html
To determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support. The first two patients in the United States treated with the novel Seraph-100 device. These cases were reviewed by the Food and Drug Administration prior to granting an emergency use authorization for treatment of coronavirus disease 2019. Case series. Vasopressor dose, mean arterial pressure, temperature, interleukin-6, C-r
Like
Comment
Share
